Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-1-7
pubmed:abstractText
The Toll (Tlr) receptors facilitate innate immunity by detecting products that are unique to invading microorganisms. Stimulation of these receptors can produce severe reactions and death. We propose that synergy between receptors for different microbial products would provide a safety mechanism, preventing inappropriate, potentially fatal reactions by reacting to low concentrations of ligands when more than a single ligand is present.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylmuramyl-Alanyl-Isoglutamine, http://linkedlifedata.com/resource/pubmed/chemical/Drosophila Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 2, http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 4, http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptors, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/endotoxin receptor
pubmed:status
MEDLINE
pubmed:issn
1079-9796
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
728-30
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11778656-Acetylmuramyl-Alanyl-Isoglutamine, pubmed-meshheading:11778656-Animals, pubmed-meshheading:11778656-Cell Line, pubmed-meshheading:11778656-Dose-Response Relationship, Drug, pubmed-meshheading:11778656-Drosophila Proteins, pubmed-meshheading:11778656-Drug Synergism, pubmed-meshheading:11778656-Ligands, pubmed-meshheading:11778656-Lipopolysaccharides, pubmed-meshheading:11778656-Macrophages, pubmed-meshheading:11778656-Membrane Glycoproteins, pubmed-meshheading:11778656-Mice, pubmed-meshheading:11778656-Receptors, Cell Surface, pubmed-meshheading:11778656-Receptors, Immunologic, pubmed-meshheading:11778656-Toll-Like Receptor 2, pubmed-meshheading:11778656-Toll-Like Receptor 4, pubmed-meshheading:11778656-Toll-Like Receptors, pubmed-meshheading:11778656-Tumor Necrosis Factor-alpha
pubmed:articleTitle
Synergy between TLR2 and TLR4: a safety mechanism.
pubmed:affiliation
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA. beutler@scripps.edu
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't